COVID-19 Response at

Read what we're doing...

Robert Ludlum's The Paris Option


Product Description
Product Details

Promotional Information

During his thirty-year career Ludlum sold 220 million copies in 40 countries in 32 different languages His recent books have been SUNDAY TIMES bestsellers and GUARDIAN fastsellers in paperback Ludlum's THE BOURNE IDENTITY and THE BOURNE SUPREMACY were both major Hollywood movies starring Matt Damon The COVERT-ONE novels have consistently sold extremely well to traditional fans and his new audience Ludlum always receives first-rate reviews: 'A writer who bests the bestsellers' DAILY TELEGRAPH 'A page-turner of non-stop action that should leave his fans begging for more' NEW YORK POST 'A fast-paced thriller from a reliable master' DAILY MAIL 'Huge in scope ... Ludlum spins it all together with lots of suspense' SUNDAY TELEGRAPH 'A master at the conspiracy theory type of thriller, his books operate on an ever-spiralling series of surprise revelations' IRISH TIMES 'Ludlum stuffs more surprises into his novels than any other six-pack of thriller writers combined' NEW YORK TIMES 'The real titan of the genre is Robert Ludlum' GQ

About the Author

After a successful career in the theatre, Robert Ludlum launched his career as a best-selling writer with THE SCARLATTI INHERITANCE in 1971, the first of twenty-two consecutive international bestsellers. Robert sadly passed away in March 2001. Gayle Lynds is the co-author of three Covert-One novels and is the author of several bestselling thrillers.


After a 30-year career that engendered dozens of bestselling novels of international intrigue, Ludlum died in the spring of 2001, just before publication of The Cassandra Compact, the second title in the Covert-One biotech series. This third Covert-One opus co-written with spy novelist Gayle Lynds (Mosaic), who also worked on the first Covert-One epic, The Hades Factor reprises the over-the-top, almost parodic tone of its predecessors with more antics from undercover agent army Lt. Col. Jonathan Smith, M.D. A horrific explosion destroys the Paris lab of computer genius Emile Chambord on the eve of his breakthrough in the development of a revolutionary molecular DNA computer that has the ability to control virtually all the world's computerized operations. Overnight, military satellites, international data banks and worldwide communications threaten to crash. Faced with the enormity of this malevolent power play, Dr. Jon Smith sets out to find the perpetrators. Arriving in Paris just as Chambord's daughter, Thrse, is being abducted, Smith trails the terrorists to Toledo, Spain. Just when this thrilling setup promises a return to vintage Ludlum, Smith's corny pals, CIA spook Randi Russell and British MI6 spy Peter Howell, pop up and they all go bumbling across Europe to avert a nuclear holocaust. Gainsaying the old saw, "You can't take it with you," Ludlum bequeaths yet another ghostly burlesque of his fabled plotting talents. Major ad/promo. (June 18) Copyright 2002 Cahners Business Information.

Ask a Question About this Product More...
Write your question below:
How Fishpond Works
Fishpond works with suppliers all over the world to bring you a huge selection of products, really great prices, and delivery included on over 25 million products that we sell. We do our best every day to make Fishpond an awesome place for customers to shop and get what they want — all at the best prices online.
Webmasters, Bloggers & Website Owners
You can earn a 8% commission by selling Robert Ludlum's The Paris Option on your website. It's easy to get started - we will give you example code. After you're set-up, your website can earn you money while you work, play or even sleep! You should start right now!
Authors / Publishers
Are you the Author or Publisher of a book? Or the manufacturer of one of the millions of products that we sell. You can improve sales and grow your revenue by submitting additional information on this title. The better the information we have about a product, the more we will sell!
Item ships from and is sold by, Inc.
Back to top